(Deficit) Unappropriated 363.61 426.45 491.34 Total Shareholders’ Equity 463.61 526.45 591.34 Income Statement Revenue from Sale of Goods and Rendering of Services 466.56 568.04 618.45 Cost of Sale of Goods
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator
transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
acquired Value of the Company’s securities paid-up shares None Ref. WINNER 0009/20108 Page 5 of 10 transferred on share sale and purchase date from the seller’s connected persons) and related services i.e
4,844.39 8,374.87 9,515.30 Total liabilities 804.07 3,789.45 4,706.43 Total equity 4,040.33 4,585.42 4,808.87 Total revenue 128.86 421.73 180.10 Cost of sale and services 119.55 149.51 126.45 SG&A 87.96
5.84 40.07 Total Equity 13.07 24.80 24.91 Total Revenue 12.01 11.98 5.91 Net Profit 8.89* 2.72 (0.11) Remark: *IGEN-ENERGY booked profit from debt discharge amounting 9.61 million. 8. Expected benefit to
% Revenue Structure Hotel 6% Property development 86% Food and beverage 5% Management service 1% Revenue from hotel operations which is the revenue from hotel services including other services such as
which was long term, lower from Bt98bn. Shareholders’ equity was Bt37,656mn, declining 12% due to lower retained earnings. Current ratio stood at 0.43x, down from 0.46x in 4Q16. With improving EBITDA and
Limited | 11 payables to contractors mainly for Methyl Ester Plant 2 construction which increased Baht 230 million, others payables for services increased Baht 55 million, and there was repayment for short
-current liabilities 740.34 273.12 467.22 Total liabilities 1,304.62 1,843.84 (539.22) Equity 839.43 253.87 585.56 Consolidated financial information Page 4 of 19 • Inventories reduced by Baht 9.86 million